SPARCL1 and Alzheimer disease: Recent evidence supports that astrocytic Hevin/SPARCL‐1 exerts a central role in the cognitive impairment observed during normal aging, and in the course of AD pathogenesis (Strunz et al. 2019; Gan and Südhof 2019, 2020).